EADV 2018 Congress - Conference Review, reviewed by Professor Pablo Fernández Peñas

In this review:

Targeting the JAK/STAT pathway
The clinical impact of the JAK/STAT pathway
Psoriasis, psoriatic arthritis and beyond
Alopecia areata and vitiligo
Atopic eczema
Late breaking news
Efficacy & safety of Janus kinase inhibitors in alopecia areata
Secukinumab for moderate-to-severe hidradenitis suppuritiva
Efficacy of an anti-IL-36 receptor antibody in acute generalised pustular psoriasis
First-in-human study: an anti-oncostatin M receptor beta MAB in atopic dermatitis
A selective inhibitor of TYK2 in moderate-to-severe psoriasis
Tight-controlled dose-reduction of biologics in psoriasis patients

Please login below to download this issue (PDF)